Loading
Latest filing published 03 Dec 2021 for Marinomed Biotech AG, €1.5M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Pascal Schmidt (finance chief) discloses dealings in Marinomed Biotech AG to FMA (OeKB OAM). Over a trading history stretching from 16 December 2020 to 2 December 2021, the count stands at 2 filings.
The open-market record is one-sided, with 2 purchases worth €2.9M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. So far in 2021, the count stands at 1 purchase and no sales.
The record was last updated on 3 December 2021 with an open-market purchase (€1.5M) in Marinomed Biotech AG. These figures are compiled from regulatory filings published by FMA (OeKB OAM). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations